Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Drug and Biotech Stocks

Biotech companies scored big in the third quarter

by William J. Storck
October 17, 2005 | A version of this story appeared in Volume 83, Issue 42


 THIRD-QUARTER STOCK PRICEaCHANGE FROM SECOND-QUARTER CLOSECHANGE FROM 2004 CLOSEPRICE/ EARNINGS RATIOb
 HIGHLOWCLOSE
MAJOR PHARMACEUTICAL COMPANIES
Abbott Laboratories$49.99$41.94$42.40-13.5%-9.1%18.0
Baxter International40.9537.0839.877.515.420.3
Bristol-Myers Squibb25.2723.9724.06-3.7-6.114.8
Eli Lilly & Co.57.2652.5253.52-3.9-5.719.2
Johnson & Johnson65.1861.9463.28-2.6-0.218.9
       
Merck31.9527.2127.21-11.7-15.310.5
Pfizer27.6024.8024.97-9.5-7.111.7
Schering-Plough22.4518.4821.0510.40.8100.2
Wyeth46.5144.0046.274.08.615.8
C&EN pharmaceuticalindex c (1992 = 100)367.5350.0351.4-3.1%-2.0% 
Dow Jones industrialaverage10705.610270.710568.72.9%-2.0% 
       
BIOPHARMACEUTICAL AND DRUG DISCOVERY COMPANIES
Amgen86.1760.8679.6731.824.228.3
Biogen Idec42.8034.0839.4814.6-40.727.4
Celera Genomics13.0010.7812.1310.6-11.8def
Cephalon46.9838.4746.4216.6-8.816.3
Chiron44.3434.9643.6525.131.0128.4
       
Cytogen5.413.684.04-22.8-64.9def
Genentech94.7479.8684.214.954.781.0
Genzyme75.2059.7071.6419.223.434.3
Gilead Sciences48.7640.9948.7610.839.439.0
Icos27.7721.1427.6230.5-2.3def
       
MedImmune33.6526.7933.6525.924.1129.4
Millennium Pharmaceuticals11.099.149.330.6-23.1def
Protein Design Labs29.9220.1228.0038.535.5def
Vertex Pharmaceuticals22.3515.5322.3532.6111.4def
Xoma1.941.411.764.8-32.1def
C&EN biopharmaceutical index d (1992 = 100)534.2447.7528.918.6%13.0% 
NASDAQ2218.22057.42151.74.6%-1.1% 

a Adjusted for stock splits.

b As of Sept. 30, 2005.

c Based on the average stock price for the nine drug companies listed.

d Based on the average stock price for the 15 biopharmaceutical companies listed.

def = deficit in previous four quarters.


Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.